CLINICAL_TRIALS
trial_result
· 2019-08-07
Clinical Trial Update: Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer [Phase 3]
Summary
Phase 3 trial comparing ABP 980 to trastuzumab in HER2-positive early breast cancer completed with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2019-08-07